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Podiatry screening of children is a common practice, which occurs largely without adequate data to support the
need for such activity. Such programs may be either formalised, or more ad hoc in nature, depending upon the use
of guidelines or existing models. Although often not used, the well-established criteria for assessing the merits of
screening programs can greatly increase the understanding as to whether such practices are actually worthwhile.
This review examines the purpose of community health screening in the Australian context, as occurs for
tuberculosis, breast, cervical and prostate cancers, and then examines podiatry screening practices for children with
reference to the criteria of the World Health Organisation (WHO). Topically, the issue of paediatric foot posture
forms the focus of this review, as it presents with great frequency to a range of clinicians. Comparison is made with
developmental dysplasia of the hip, in which instance the WHO criteria are well met. Considering that the burden
of the condition being screened for must be demonstrable, and that early identification must be found to be
beneficial, in order to justify a screening program, there is no sound support for either continuing or establishing
podiatry screenings for children.
Keywords: Screening, Paediatric, Foot, Flatfeet, ChildrenBackground
Children’s foot conditions are a frequent cause of paren-
tal concern, and as a result, regularly present to a range
of medical and health care clinicians. Whilst a variety of
issues may arise, (e.g. warts, curly toes, footwear, in-
grown nails), foot posture and especially flat feet is a
dominant concern. Indeed, the foot has been found to
be the most common musculoskeletal region presenting
to general practice in the UK [1]. However, the level of
presenting concern of foot posture problems in children
may not necessarily reflect a demonstrated level of frank
pathology. Given that paediatric flatfoot has been cited
as the most common presentation in paediatric ortho-
paedic clinics [2,3], and that the consensus from epi-
demiological findings is that paediatric flatfoot reduces
with age and is mostly asymptomatic [4], the rationale
for screening programs becomes curious.
This discussion paper has been generated in response
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reproduction in any medium, provided the orschools and schools to offer podiatry screenings for chil-
dren. Concerns relating to this practice have been
reported both formally and informally from members of
the public, and medical and health professionals. In re-
sponse to such concerns the Australian Podiatry Associ-
ation (South Australia), developed guidelines for
screening in 1998, with revision in 2008. A summary of
these guidelines is provided in Table 1.
Criteria for screening programs, regardless of the con-
dition/s to be detected are well recognized [5], although
often overlooked or not considered. This paper aims to
critically review the issue of foot screening for children,
and to establish whether such programs are indicated,
based upon previously developed criteria for screening
programs (WHO) which have been used for the ocular
condition, amblyopia [6].Lessons from previously reported foot screenings
In 1967, Shapiro and Rhee conducted screenings at a
time when unsubstantiated opinions about foot condi-
tions (e.g. “many of the foot disorders in adults begin in
childhood”) were accepted, rather than tested [7]. As a
result, the findings must be seen in that light. This seriesis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 A summary of the guidelines from The Australian Podiatry Association (South Australia) in 2008 for
podiatrists’ visits to children’s centres/preschools for paediatric foot screening
Section Area covered Basic content
1 General Purpose of the document and definitions
2 Policy Australian Podiatry Association (South Australia) policies for members
3 Guidelines Obtaining consent from all relevant bodies
4 Protocol Outline of the visit format and content
5 Appendices - consent form for parents
- report form of examination findings for parents
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period, and found the most frequently encountered pro-
blems to be postural or orthopaedic, and most fre-
quently this was flatfeet. Given that more than half of
the subjects were less than six years old, this finding is
now seen as an expected part of development, but at the
time was seen as justification to continue screening (and
subsequently examining ‘positive’ cases further, and insti-
gating treatment).
Almost 40 years later, El et al. conducted a screening
in 579 school children (mean age 9.23 years) and found
significant and inverse correlation between flatfeet,
hypermobility and age. These authors concluded that
flexible flatfoot and joint hypermobility both reduce de-
velopmentally [3]. In the same year Pfeiffer examined
835 children aged three to six years and found
increased flatfoot posture in boys, in younger children,
and in overweight or obese children. Pathological flat-
foot was detected in less than one percent of subjects,
yet 10% were being treated for their flatfoot posture,
giving rise to the conclusion that 90% of treatment was
unnecessary [8].
The principles of screening
The World Health Organization (WHO) defines screen-
ing as: “the presumptive identification of unrecognised
disease or defects by means of tests, examinations or
other procedures that can be applied rapidly” [5].
Further to this, the WHO stipulates that screening is
intended for all people, in an identified target popula-
tion, who do not have symptoms of the particular dis-
ease or condition. The screening process can then
potentially identify: a pre-disease abnormality, early dis-
ease, or disease risk markers.
The aim of screening for a disease, or a risk marker
for a disease, is to reduce the costs of the disease in the
community–including incidence of disease, morbidity or
mortality. This is achieved by intervening to reduce indi-
vidual risk of the disease, or detecting the disease earlier
than is usually the case in the absence of screening, and
hence improving disease outcome.
Clearly the impact of the disease or condition must
be demonstrable, and early identification found to bebeneficial, in order to justify any screening program.
There must be evidence that early diagnosis and treat-
ment increases the chances of successfully treating or
managing the disease.
Whilst screening can reduce the risk of developing or
dying from a disease, it does not guarantee that disease
will not occur, or if it occurs, that it can be cured. A
‘positive’ screening test identifies people who are at
increased likelihood of having the condition and who re-
quire further investigation to determine whether or not
they have the disease or condition.
As screening has benefits, costs, and also potential
harms, there is an ethical obligation to maximize bene-
fits and minimise harm; and the overall benefits should
outweigh any harms that result from screening. In
addition, when community resources are used to fund
screening there should be community consensus that
the benefits of screening justify the financial expense of
undertaking the screening.
Health screening in Australia
Undetected but untreated, tuberculosis, and cancers of
the breast, cervix and prostate gland result in death and
suffering. Early treatment gives the best outcomes for
survival, and screening has been demonstrably effective
in reducing incidence, morbidity and death [9].
As outlined within the Australian Health Ministerial
Advisory Council (AHMAC) Australian Population
Health Development Principal Committee Population
Based Screening Framework (2008), in Australia, screen-
ing programs currently occur for: tuberculosis; breast,
cervical, and bowel cancers [10]. It is pertinent here, to
briefly review each condition.
Tuberculosis (TB) screening: reduces incidence, illness and
deaths
Most individuals infected with Mycobacterium tubercu-
losis remain asymptomatic, but there is a 10% lifetime
risk of developing clinical illness, sometimes many years
after the original infection. The World Health Orga-
nization (WHO) declared tuberculosis a global emer-
gency in 1993, and recent reports have reaffirmed the
threat to human health. About 1,000 cases of TB are
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yearly notification rate for TB has stabilised at approxi-
mately 5 to 6:100,000 since 1985.
In Australia, most TB cases (> 80%) occur in people
born overseas, particularly in Asia, eastern Europe, the
Pacific Islands, and sub-Saharan Africa. The rates of TB
in the overseas-born population have been slowly in-
creasing over the past decade. Rates of TB are also high
in Aboriginal and Torres Strait Islander people and in
Papua New Guineans living in some parts of Australia.
Patients with impaired immunity are at high risk of
developing active TB if they are infected with M. tuber-
culosis. Screening programs in Australia now target
those at high risk, which includes those in contact with
affected patients (Figure 1).
Vaccination programs for TB uses the BCG (Bacille
Calmette-Guérin) vaccine, and whilst globally, many
BCG vaccines are available, all are derived from the
Institut Pasteur, which was first used in humans in 1921.
BCG is primarily intended for children as meta-analyses
have found the protective efficacy for preventing serious
forms of TB in this group is over 80%. Protective efficacy
in all age groups is about 50%.
The Australian cancer council has summarized the tar-
geted approach to screening for breast, cervical and
bowel cancers [11].
Breast cancer screening: reduces morbidity and mortality
Breast cancer is the second most common cancer affect-
ing Australian women (after non-melanoma skin can-
cer), and the second most common cause of death in
Australian women. Breast cancer screening in Australia
targets women aged between 50 to 69 years, who are
most affected. Early detection of breast cancer has been
found to give the best chance of reducing both morbid-
ity and mortality [11].Figure 1 The framework used for population based screening progra
Framework, Australian Health Ministerial Advisory Council (AHMAC), 2008.Cervical cancer screening: reduces incidence and deaths
More than 730 new cases of cervical cancer occur in
Australian women each year, and results in approxi-
mately 210 deaths in women annually. Since 1991 when
cervical cancer screening commenced in Australia, the
incidence of cervical cancer in women aged 20 to
69 years has almost halved, saving approximately 1,200
women from developing cervical cancer each year [11].
Bowel cancer screening: reduces incidence and deaths
Bowel cancer affects 1:12 Australians by age 85 years,
making it the third most common cancer (after skin and
prostate cancers), and the second most common cause
of cancer deaths in Australia (after lung cancer). There
is a demonstrated 90% cure rate with early detection and
treatment. The current screening program targets those
turning 50, 55 and 65 years between January 2011 and
December 2014 [11].
In 1968, Wilson and Jungner developed the WHO
principles of screening [5]. These are outlined in Table 2,
and expanded upon below within the context of paediat-
ric podiatry foot (posture) screenings.
Application of screening principles to the
paediatric foot
This discussion of whether the paediatric foot is a suit-
able target for community screening has been generated
by the increasing propensity for screening programs,
without adequate data to develop a clear understanding
of how effective these programs are likely to be. The
criteria by which a potential screening program should
be judged, whatever the condition to be detected, are
well recognised. These criteria are often overlooked
altogether, or only considered in part, in the establish-
ment of screening programs. Podiatry screening pro-
grams of varying nature exist in many communities, andms in Australia. Reproduced from: Population Based Screening
Table 2 The WHO criteria help to distinguish between
population-based screening and opportunistic
case-finding
WHO Principles of Early Disease Detection
Condition
• The condition should be an important health problem.
• There should be a recognisable latent or early symptomatic stage.
• The natural history of the condition, including development from latent
to declared disease should be adequately understood.
Test
• There should be a suitable test or examination.
• The test should be acceptable to the population.
Treatment
• There should be an accepted treatment for patients with recognised disease
Screening Program
• There should be an agreed policy on whom to treat as patients.
• Facilities for diagnosis and treatment should be available.
• The cost of case-findings (including diagnosis and treatment of patients
diagnosed) should be economically balanced in relation to possible
expenditure on medical care as a whole.
• Case-findings should be a continuing process and not a ‘once and for
all’ project.
Reproduced from: Principles and practice of screening for disease, WHO, 1968.
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defined goals can include ‘prevention’, or the early detec-
tion and treatment of ‘foot problems’—the notion of
which is inherently unsubstantiated for paediatric flat-
foot [12]. Here then, we review critically whether such
programs are either helpful or appropriate, by consider-
ing how well paediatric foot problems (viz. flatfoot) ful-
fils each of the following WHO criteria for a screening
program.
Condition
(i) The condition should be an important health
problem.
Prevalence studies of paediatric flatfoot have
returned a wide range of estimates from 0.6–77.9%,
due to differing age groups, assessment measures
and population samples [4]. The findings of
developmental flatfoot across age groups
approximate 45% in pre-school children and 15% in
children with mean age of 10 years. The rate of
paediatric flatfoot may be higher with joint
hypermobility [13], increased weight or obesity
[14], in males [8], with specific neuromuscular [15]
and genetic conditions (e.g. Down’s syndrome) [16],
or with a positive family history [8]. However,
reported prevalence varies among studies according
to the populations examined, and the tests andcriteria used. Despite being so common, there is
little known about the long-term consequences of
paediatric flatfoot–vital knowledge in determining
the importance of the condition [17].
Whilst the premise of preventing foot problems
from either existing or developing in childhood are
notionally admirable, there is a lack of evidence
from prospective data to demonstrate which
pediatric flat feet require, and may benefit from,
treatment [4]. It is sensibly accepted that painful
paediatric flatfeet warrant intervention [18], but it
is also pertinent to note that some paediatric foot
pain may be transient and attributed to normal
osseous development alone (e.g. Sever’s disease),
and not attributable to foot posture alone. It is also
the case that most paediatric flatfeet, especially in
the first decade of life, do not present with overt
symptoms. In such instances it is largely the
appearance of the foot morphology which concerns
parents and sometimes clinicians [19-21]. There is
understandably, an impetus to avoid future
problems and feared disability due to extrapolated
foot pain (more commonly seen in adults), but in
healthy children where flatfoot developmentally
reduces with age, this is an unfounded concern. It
is very important that the paediatric flatfoot is well
assessed, as this provides the opportunity to filter
the normal physiologic flatfeet from those related
to other known associations, including joint
hypermobility, overweight or obesity, or specific
disease groups. The paediatric flatfoot proforma
(p-FFP) provides an assessment framework which
standardises both assessment andmanagement,
according to the currently available best evidence [22].
Some flatfeet, either within or continuing from
childhood, will be come painful and hence require
treatment. However, there is no known a priori test
that definitively detects the errant cases, and hence
treatment of paediatric flatfeet requires either the
presentation of symptoms or clinically assessed
functional deficits, to warrant intervention. In turn,
any interventions need to be assessed for need,
benefit and efficacy against pre-specified outcome
measures.
(ii) There should be a recognisable latent or early
symptomatic stage.
Some factors may, independent of development,
predispose children to flatfeet which are not
considered normal. Hypotonia, is a good example
of a condition which is often detected before foot
posture becomes relevant (i.e. before walking is
expected) and which may be related to delayed
motor milestones [23]. However, it is difficult to
ascertain what proportion of infants who are
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affected in terms of motor delays involving foot
posture (stance and gait onset), as the presentation
and pathway is highly variable, and generally
diluted by age. Hence, even given the identification
of a factor more likely (but not assuredly) to herald
increased paediatric flatfoot, prediction of the need
for treatment remains uncertain, making the issue
of a recognizably latent period rather fraught.
(iii) The natural history of the condition, including
development from latent to declared disease should
be adequately understood
The natural history of foot posture development is
well documented, and whilst assessment
techniques, samples, ethnicities and age ranges
have varied, there is uniform consensus that the
‘flatness’ of paediatric foot posture reduces
normally with age [20,24-26]. It is not fully
understood why and at what age children develop
out of the physiologic flatfoot posture, although
good assessment of the wider developmental status
(i.e. muscle tone, connective tissue quality,
strength, genetic factors, antenatal growth, obesity,
gender, inheritance, shoe use) yields clinically useful
indicators [27]. In order for guidelines for
necessary and beneficial treatment to be effective,
the natural history of normal from aberrant foot
posture development needs to be known, in both
healthy children and those with an underlying
diagnosis (e.g. juvenile arthritis, cerebral palsy,
Down’s syndrome, diabetes mellitus).
Test
(i) There should be a suitable test or examination.
Ideal screening tests have been described as having
the following characteristics: simple, quick and easy
to interpret; acceptable to the public (who
participate voluntarily); accurate; repeatable,
especially between observers; and sensitive and
specific (rules the condition ‘in’ and ‘out’) [28].
It is easy to understand the appeal of foot-printing
as a screening test for foot posture in children, as it
is certainly quick, simple and at face value, easy to
interpret. However the validity of foot printing to
ascertain foot skeletal morphology is uncertain
[29-31] if still frequently used [32-35]. Foot posture
assessment in children has been less examined than
in adult subjects, but the easiest and demonstrably
reliable tools are the foot posture index (FPI-6)
[31,36], from which ‘pronated’ cases (scores ≥ +6)
can be identified and then classified and managed as
directed by the paediatric flatfoot proforma (p-FFP)
[22] (Figures 2, 3 and 4). The range of statisticallynormal values needs to be appreciated by clinicians.
Neither the FPI-6 nor the p-FFP has adequate
sensitivity and specificity, which limits application.Treatment
(i) There should be an accepted treatment for patients
with recognised disease.
Is it either possible or necessary to prevent or
reverse paediatric flatfoot? Given that normal
physiological development sees reduced numbers of
flatfoot posture with age, in a sense ‘reversible’–but
as a part of its natural history. Given too, that it is
from the commencement of the second decade of
life, flatfoot posture is by definition less normal, this
is perhaps the age group where prevention and
reversibility are best focused.
Harking back to the issues that may modulate the
natural history of paediatric foot posture
development, it is useful to look at these factors in
terms of those that might be able to respond to
external effect (viz treatment). The factors
previously listed were: muscle tone, connective
tissue quality, strength, genetic factors, antenatal
growth, obesity, gender, inheritance, shoe use [27].
As a pragmatic approach, these factors have been
categorised as ‘easy’ or ‘difficult’ to influence
clinically. Strength [37,38], obesity/overweight [8,33],
and shoe use [39] are the ‘easy’ factors which may
be altered so as to possibly influence foot posture
and resulting gait [8,33,37-39]. Muscle tone,
connective tissue quality, genetic factors, antenatal
growth, gender, and hereditary factors are ‘difficult’,
if not impossible areas to change. Having said that,
both hypotonia and connective tissue hypermobility
may reduce with age [13].
However, the very issue of the need for treatment
for paediatric flatfoot is tenuous, given the lack of
supportive evidence for any asymptomatic cases,
which form the majority [40]. Bluntly stated, if the
paediatric flat foot cannot be definitively
demonstrated to have definite and deleterious
consequences in later life (when treatment can be
instituted anyway), there may simply be no need for
concern about the foot posture of healthy children.
On the other hand, children who arrive at the end
of their first life decade with very flatfeet, if usually
asymptomatic, may be worth monitoring,
strengthening, advising about footwear selection and
overweight/obesity influence. Further research is
required to determine which factors at which age,
are associated with symptomatic flatfeet, such that
any possible prevention may be reasonably employed
[4,12]. Until this information is available the benefits
Figure 2 This algorithm displays the best available evidence for assessing and managing flatfoot in children is derived from the
paediatric flatfoot proforma (p-FFP). Reproduced from: A Cochrane review of the evidence for non-surgical interventions for flexible pediatric
flat feet, Evans AM, Rome K (2011) European Journal of Physical Rehabilitation Medicine 47(1): 69–89.
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questionable.Screening program
(i) There should be an agreed policy on whom to treat
as patients.
It is agreed that children with painful flatfeet
should be treated. It is also agreed that the ‘flat’
paediatric foot posture normally reduces with age
across the first decade of life. It is further agreed
that some conditions and groups with an
underlying diagnosis have a greater propensity
toward increased paediatric flatfoot deformity (e.g.
cerebral palsy, Ehlers Danlos).
The p-FFP designates treatment according to
‘traffic light’ colours: i.e. ‘red’ for painful flatfeet–treatment indicated; ‘yellow’ for children >8 to
10 years old with asymptomatic flatfeet–monitor,
and perhaps use simple measures such as
footwear support; ‘green’ for flatfeet in young
children where this is the developmental ‘norm’
(not discounting young children diagnosable with
wider and underlying diagnoses). There can be
little contention about the ‘red’ and ‘green’ groups
with respect to the respective need for treatment,
and the normal physiological foot posture growth.
However, the designated ‘yellow’ group has
aroused considerable debate in some quarters
[17,41-43], as has the findings of the Cochrane
review which states that: “in the absence of
symptoms there is no evidence to support the
use of customised foot orthoses in asymptomatic




Figure 3 The statistical definition of ‘normal’ is the area under the curve, which is two standard deviations either side of the
population mean. This represents 95% of any normally distributed sample, such that only 2.5% are above and below these values. Reproduced
from: http://michaelsrickert.wordpress.com/2012/02/06/what-is-your-emr-bell-curve/.
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systematic review have consolidated much of the
debate, there is as yet no truly universal policy
on whom to treat, nor when or how to treat
children with flexible flatfeet. Thorough
assessment using the FPI-6 to filter, and theure 4 The Scatter plot of FPI scores according to age, hence illustrat
uction of the same with increasing age. Reproduced from: Normative v
8), Journal of Foot and Ankle Research 1(6).p-FFP to classify, would seem to be the best
current approach.
(ii) Facilities for diagnosis and treatment should be
available.
It is very difficult to justify any resources for wider
diagnosis (let alone treatment) of paediatric flatfoot.e the normal presence of a flat foot posture in childhood, and
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asymptomatic cases, which are the majority of
clinical presentations. It is particularly difficult to
justify screening programs for children less than 8
to 10 years of age, given the natural history of the
resolution of ‘flat’ foot postures [26].
(iii) The cost of case-findings (including diagnosis and
treatment of patients diagnosed) should be
economically balanced in relation to possible
expenditure on medical care as a whole.
Given the questionable relevance of the flexible
paediatric flatfoot, and given the normal
developmental profile of the same, it is unlikely
that screening programs are ultimately cost-
effective. The costs of failing to detect paediatric
flatfoot are not evident, as most resolve
physiologically over time, and those remaining will
not definitely result in disability.ble 3 The WHO principles of early disease detection applied
aediatric flat foot posture
HO criteria DDH
he condition should be an important
alth problem.
Uncorrected DDH results
gait dysfunction and earl
here should be a recognisable latent or
rly symptomatic stage
Mostly detectable and re
he natural history of the condition, including
velopment from latent to declared disease
ould be adequately understood.
Some DDH normalizes in
of life; controversy about
long to monitor in cases
Recognisable risk factors
birth, female, left hip affe
history of DDH [50].




he test should be acceptable to the
pulation.
Clinical examination and
later x-rays) are acceptab
here should be an accepted treatment for
tients with recognised disease.
Abduction splinting foun
effective [52].
here should be an agreed policy on whom
treat as patients.
It is agreed that DDH be
the chance of serious pa
controversy regarding th
treatment, given that som




he cost of case-findings (including diagnosis
d treatment of patients diagnosed) should
economically balanced in relation to possible
penditure on medical care as a whole.
Late diagnosis increases
increased need for surge
ase-findings should be a continuing process
d not a ‘once and for all’ project.
Routinely occurs from bir
paediatric health checks.The costs of screening programs will include staff
time, equipment and the additional setting up
procedures. There are also the subsequent wider
health costs of referral for further evaluation and
possible treatment (which may be nett cost versus
gain, if unnecessary treatment occurs).
Less measurable is the cost of parental concern
that can be generated from receipt of evaluations
designating their child as having “abnormal” feet
and “requiring attention”. Most concerning of all is
the unnecessary cost of any ‘automatic’ and
subsequent treatment, especially customised foot
orthoses for young, asymptomatic children–given
the evidence against this approach.
(iv) Case-findings should be a continuing process and
not a ‘once and for all’ project.
Isolated one-off screening programs at sites of




Indefinite prognosis for flexible flat feet,
but rigid flat feet usually require
treatment [48]
versible from birth Most flat feet are asymptomatic in the
first decade of life
the first few months
when to treat, how
of instability [49].
in newborns are: breech
cted, first born, family
A flat foot posture is expected in infants,
and normally reduces with age.
Recognisable associations with non-
resolving flat feet may include: male,
overweight or obesity, hypermobility,
wider conditions e.g. Down’s, family




FPI-6 ≥ +6 indicates suitability of the




No universally accepted definition for
flat foot. [40].
d to be safe and In the absence of symptoms, the
indication for treatment is uncertain
and should only be used when clinically
definable outcomes can be improved.
treated early to reduce
thology. There is some
e age to commence
e cases resolve.
The best available evidence supports
treating rigid or symptomatic flexible
flatfeet [48]. There is no clear evidence
to support the treatment of most
asymptomatic cases, especially in
younger children [25]
ultrasound are Observation, the FPI-6 and the p-FFP are




th and early Not indicated
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foot screenings, and as with any other screening
programs, there is much less likelihood of valuable
findings unless linked to a regular health
surveillance project. Once again however, it is
extremely difficult to see any justification for a
specific foot component to paediatric health
screenings, given that the most significant
paediatric foot deformity, i.e. clubfoot, is detected
at (or before) birth in developed countries [44,45].Comparison with developmental dysplasia of the
hip (DDH)
The hips of newborn babies have long been routinely
examined for dislocation, subluxation and instability.
Developmental dysplasia of the hip (DDH) left uncor-
rected, is associated with long-term morbidity, including
chronic pain, abnormal gait and arthritis [46]. Pertinent
is that when detected early, DDH is very treatable with
non-invasive, inexpensive methods (splinting, harnesses),
with good results [47].
Applying the WHO principles of early disease detec-
tion to both paediatric DDH and flat feet provides clear
comparison of both the need for, and benefits from,
screening programs (Table 3). Screening for DDH
adheres to the WHO principles, which justifies screening
programs for the infant hip. This is not the case for
asymptomatic flatfeet in children.
Conclusions
Despite the regular occurrence of podiatry screenings
for children (with focus of foot posture), there is no
good evidence to deem such activities as warranted,
given both the natural history of paediatric foot morph-
ology, the largely asymptomatic presentation, and the
lack of evidence to support treatment. The application
of the WHO criteria to justify screenings, clearly negate
the need for such practice, and until there is evidence to
the contrary, podiatry screenings for children not related
to formalized research protocols, appear neither neces-
sary nor appropriate.
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